Once-daily saxagliptin added to metformin provides sustained glycaemic control and is well tolerated over 102 weeks in patients with type 2 diabetes R DeFronzo, MN Hissa, A Garber, J Luiz Gross, RY Duan, ... Bristol-Myers Squibb, 2009 | 86 | 2009 |
Effects of saxagliptin on β‐cell stimulation and insulin secretion in patients with type 2 diabetes RR Henry, SR Smith, SL Schwartz, SR Mudaliar, CF Deacon, JJ Holst, ... Diabetes, Obesity and Metabolism 13 (9), 850-858, 2011 | 81 | 2011 |
Hydroxyoctadecadienoic acids regulate apoptosis in human THP-1 cells in a PPARγ-dependent manner VN Vangaveti, VM Shashidhar, C Rush, UH Malabu, RR Rasalam, ... Lipids 49, 1181-1192, 2014 | 37 | 2014 |
General Practice Management of Type 2 Diabetes: 2014-15 G Deed, E Ackermann, R Newman, R Audehm, I Arthur, J Barlow, ... Royal Australian College of General Practitioners (RACGP), 2014 | 36 | 2014 |
Growth of the James Cook University Medical Program: Maintaining quality, continuing the vision, developing postgraduate pathways T Sen Gupta, P Johnson, R Rasalam, R Hays Medical Teacher, 1-6, 2018 | 23 | 2018 |
Sodium‐glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review R Rasalam, JJ Atherton, G Deed, M Molloy‐Bland, N Cohen, A Sindone ESC Heart Failure 8 (5), 4093-4118, 2021 | 20 | 2021 |
Virtual WIL clinics in medicine: Overcoming the COVID-19 challenge R Rasalam, S Bandaranaike International Journal of Work-Integrated Learning 21, 573-585, 2020 | 18 | 2020 |
Benefits of simulated general practice clinics in the preparation of medical students for primary healthcare K Lytton, T Woolley, R Rasalam, S Gorton, P Heggarty Education for Primary Care 30 (5), 275-281, 2019 | 14 | 2019 |
The road to registration: Aboriginal and Torres Strait Islander Health Practitioner training in North Queensland KS Hill K, Harvey N, Felton-Busch CM, Hoskins J, Rasalam R, Malouf P Rural and Remote Health 18 (1), 2018 | 14 | 2018 |
GLP-1 receptor agonists for type 2 diabetes and their role in primary care: an Australian perspective R Rasalam, J Barlow, M Kennedy, P Phillips, A Wright Diabetes Therapy 10 (4), 1205-1217, 2019 | 11 | 2019 |
Medication calculation and administration workshop and hurdle assessment increases student awareness towards the importance of safe practices to decrease medication errors in … D Wallace, T Woolley, D Martin, R Rasalam, M Bellei Education for Health 29 (3), 171-178, 2016 | 11 | 2016 |
General practice management of type 2 diabetes–2014-15. D Australia Melbourne: The Royal Australian College of General Practitioners and …, 2014 | 11 | 2014 |
Immunogenicity and safety of a bivalent (omicron BA. 5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase … C Bennett, W Woo, M Bloch, K Cheung, P Griffin, R Mohan, S Deshmukh, ... The Lancet Infectious Diseases 24 (6), 581-593, 2024 | 7 | 2024 |
Challenging Clinical Perspectives in Type 2 Diabetes with Tirzepatide, a First-in-Class Twincretin R MacIsaac, G Deed, M D'Emden, E Ekinci, S Hocking, R Rasalam Diabetes Therapy, 2023 | 7 | 2023 |
Effective primary care management of type 2 diabetes for indigenous populations: A systematic review S Chopra, TJ Lahiff, R Franklin, A Brown, R Rasalam Plos one 17 (11), e0276396, 2022 | 7 | 2022 |
General Practice Management of Type 2 Diabetes R Audehm, I Arthur, J Barlow, M Kennedy, G Kilov, S Leow, JA Manski, ... The Royal Austalian College of General Practitiones and Diabetes Australian …, 2014 | 7 | 2014 |
Short-chain fatty acids increase expression and secretion of stromal cell-derived factor-1 in mouse and human pre-adipocytes VN Vangaveti, C Rush, L Thomas, RR Rasalam, UH Malabu, ... Hormones 13, 532-542, 2014 | 4 | 2014 |
Early type 2 diabetes treatment intensification with glucagon‐like peptide‐1 receptor agonists in primary care: An Australian perspective on guidelines and the global evidence R Rasalam, S Abdo, G Deed, R O'Brien, J Overland Diabetes, Obesity and Metabolism 25 (4), 901-915, 2023 | 3 | 2023 |
Managing cardiovascular risk in type 2 diabetes: what do the cardiovascular outcome trials mean for Australian practice? G Deed, JJ Atherton, M d’Emden, R Rasalam, A Sharma, A Sindone Diabetes Therapy 10, 1625-1643, 2019 | 2 | 2019 |
Building a culture of Medical Professionalism: A case study R Rasalam, S Bandaranaike WIL: Creating Connections, Building Futures – Proceedings of the 2018 ACEN …, 2018 | 2 | 2018 |